DGLRX
Price
$21.97
Change
+$0.09 (+0.41%)
Updated
Dec 3 closing price
Net Assets
742.08M
FNPFX
Price
$74.82
Change
+$0.38 (+0.51%)
Updated
Dec 3 closing price
Net Assets
162.64B
Interact to see
Advertisement

DGLRX vs FNPFX

Header iconDGLRX vs FNPFX Comparison
Open Charts DGLRX vs FNPFXBanner chart's image
BNY Mellon Global Stock - I
Price$21.97
Change+$0.09 (+0.41%)
VolumeN/A
Net Assets742.08M
American Funds New Perspective F3
Price$74.82
Change+$0.38 (+0.51%)
VolumeN/A
Net Assets162.64B
DGLRX vs FNPFX Comparison Chart in %
View a ticker or compare two or three
VS
DGLRX vs. FNPFX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGLRX is a Buy and FNPFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FNPFX has more cash in the bank: 163B vs. DGLRX (742M). FNPFX pays higher dividends than DGLRX: FNPFX (0.74) vs DGLRX (0.41). DGLRX was incepted earlier than FNPFX: DGLRX (19 years) vs FNPFX (9 years). DGLRX (0.91) is less costly to investors than FNPFX (0.41). FNPFX is a more actively managed with annual turnover of: 24.00 vs. DGLRX (10.58). DGLRX has a lower initial minimum investment than FNPFX: DGLRX (1000) vs FNPFX (1000000). FNPFX annual gain was more profitable for investors over the last year : 11.96 vs. DGLRX (-7.71). FNPFX return over 5 years is better than : 26.20 vs. DGLRX (-16.87).
DGLRXFNPFXDGLRX / FNPFX
Total Expense Ratio0.910.41222%
Annual Report Gross Expense Ratio0.910.41222%
Fund Existence19 years9 years-
Gain YTD5.10819.53326%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets742M163B0%
Annual Yield % from dividends0.410.7455%
Returns for 1 year-7.7111.96-64%
Returns for 3 years-6.6945.12-15%
Returns for 5 years-16.8726.20-64%
Returns for 10 years16.60N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARWR57.981.73
+3.08%
Arrowhead Pharmaceuticals
BCML29.320.09
+0.31%
BayCom Corp
ABLLL25.31N/A
N/A
Abacus Global Management Inc. 9.875% Fixed Rate Senior Notes due 2028
MDAI1.49-0.02
-1.32%
Spectral AI
NEGG70.56-1.59
-2.20%
Newegg Commerce Inc